Investigating the Effects of Dorema hyrcanum Root Extracts on Selective Induction of Programmed Cell Death in Glioblastoma, Ovarian Cancer and Breast Cancer Cell Lines


Cite item

Full Text

Abstract

Background:Despite remarkable advances, cancer has remained the second cause of death, which shows that more potent novel compounds should be found. Ethnobotanical compounds have a long history of treating diseases, and several approved chemotherapeutic compounds were isolated from plants.

Objective:The research aimed to evaluate the cytotoxic effects of Dorema hyrcanum root extract on ovarian, breast, and glioblastoma cells while examining its selectivity towards normal cells. Additionally, the study is directed to investigate cell death mechanisms, delineate modes of cell death, and explore intracellular ROS production.

Methods:Cytotoxic effects of alcoholic, dichloromethane, and petroleum ether fractions of Dorema hyrcanum were investigated on cancer and normal cells by using MTT assay, and the concentration around IC50 values was used for flow cytometric assessment of apoptosis, evaluation of the expression of selected genes via RT-qPCR and production of ROS.

Results:Methanolic extract exhibited the highest cytotoxicity, impacting A2780CP and MDA-MB-231. All fractions showed comparable effects on U251 cells. Notably, extracts displayed higher IC50 values in normal HDF cells, indicating cancer cell specificity. Flow cytometry revealed induction of apoptosis and non-apoptotic death in all three cancer cell lines. QPCR results showed upregulation of related genes, with RIP3K prominently increased in U251 glioblastoma. The DCFH-DA assay demonstrated ROS induction by the PE fraction exclusively in A2780CP cells after 30 minutes and up to 24 hours.

Conclusion:Dorema hyrcanum root extracts exhibited potent anti-tumor effects against all studied cell lines. The methanolic extract demonstrated the highest cytotoxicity, particularly against A2780CP and MDA-MB-231 cells. Importantly, all fractions displayed selectivity for cancer cells over normal HDF cells. Unique modes of action were observed, with the petroleum ether fraction inducing significant non-apoptotic cell death. These findings suggest promising therapeutic potential for Dorema hyrcanum in cancer treatment with subject to further mechanistic studies.

About the authors

Mahsa Shandi

Department of Clinical Biochemistry, Shahid Beheshti University of Medical Sciences

Email: info@benthamscience.net

Shamim Sahranavard

Traditional Medicine and Materia Medical Research Center, Department of Traditional Pharmacy, School of Traditional Medicine, Shahid Beheshti University of Medical Science,

Author for correspondence.
Email: info@benthamscience.net

Fereshteh Bagheri

Department of Clinical Biochemistry, Shahid Beheshti University of Medical Sciences

Email: info@benthamscience.net

Zahra Shahsavari

Department of Clinical Biochemistry, Shahid Beheshti University of Medical Sciences

Email: info@benthamscience.net

Siamak Salami

Department of Clinical Biochemistry, Shahid Beheshti University of Medical Sciences

Email: info@benthamscience.net

References

  1. Devlin, E.J.; Denson, L.A.; Whitford, H.S. Cancer treatment side effects: A meta-analysis of the relationship between response expectancies and experience. J. Pain Symp. Manag., 2017, 54(2), 245-258. doi: 10.1016/j.jpainsymman.2017.03.017
  2. Kroschinsky, F.; Stölzel, F.; von Bonin, S.; Beutel, G.; Kochanek, M.; Kiehl, M.; Schellongowski, P. New drugs, new toxicities: Severe side effects of modern targeted and immunotherapy of cancer and their management. Crit. Care, 2017, 21(1), 89. doi: 10.1186/s13054-017-1678-1 PMID: 28407743
  3. Herrmann, J. Adverse cardiac effects of cancer therapies: Cardiotoxicity and arrhythmia. Nat. Rev. Cardiol., 2020, 17(8), 474-502. doi: 10.1038/s41569-020-0348-1 PMID: 32231332
  4. Seitz, H.K.; Pöschl, G.; Simanowski, U.A. Alcohol and cancer. Recent Dev. Alcohol., 1998, 14, 67-95. PMID: 9751943
  5. Roy, P.S.; Saikia, B.J. Cancer and cure: A critical analysis. Indian J. Cancer, 2016, 53(3), 441-442. doi: 10.4103/0019-509X.200658 PMID: 28244479
  6. Safarzadeh, E.; Sandoghchian Shotorbani, S.; Baradaran, B. Herbal medicine as inducers of apoptosis in cancer treatment. Adv. Pharm. Bull., 2014, 4(1), 421-427. PMID: 25364657
  7. Soltanian, S. The effect of plant-derived compounds in targeting cancer stem cells. J. Qazvin Uni. Med. Sci., 2019, 23(2), 164-181. doi: 10.32598/JQUMS.23.2.164
  8. Abdulridha, M.K.; Al-Marzoqi, A.H.; Al-awsi, G.R.L.; Mubarak, S.M.H.; Heidarifard, M.; Ghasemian, A. Anticancer effects of herbal medicine compounds and novel formulations: A literature review. J. Gastrointest. Cancer, 2020, 51(3), 765-773. doi: 10.1007/s12029-020-00385-0 PMID: 32140897
  9. Koren, E.; Fuchs, Y. Modes of regulated cell death in cancer. Cancer Discov., 2021, 11(2), 245-265. doi: 10.1158/2159-8290.CD-20-0789 PMID: 33462123
  10. Yan, G.; Elbadawi, M.; Efferth, T. Multiple cell death modalities and their key features (Review). World Acad. Sci. J., 2020, 2(2), 39-48. doi: 10.3892/wasj.2020.40
  11. Mottaghipisheh, J.; Vitalini, S.; Pezzani, R.; Iriti, M. A comprehensive review on ethnobotanical, phytochemical and pharmacological aspects of the genus Dorema. Phytochem. Rev., 2021, 20(5), 945-989. doi: 10.1007/s11101-020-09727-z
  12. Amiri, M.S.; Joharchi, M.R. Ethnobotanical knowledge of Apiaceae family in Iran: A review. Avicenna J. Phytomed., 2016, 6(6), 621-635. PMID: 28078243
  13. Zibaee, E.; Amiri, M.S.; Boghrati, Z.; Farhadi, F.; Ramezani, M.; Emami, S.A.; Sahebkar, A. Ethnomedicinal uses, phytochemistry and pharmacology of Dorema species (Apiaceae): A review. J. Pharmacopuncture, 2020, 23(3), 91-123. doi: 10.3831/KPI.2020.23.3.91 PMID: 33072410
  14. Zugazagoitia, J.; Guedes, C.; Ponce, S.; Ferrer, I.; Molina-Pinelo, S.; Paz-Ares, L. Current challenges in cancer treatment. Clin. Ther., 2016, 38(7), 1551-1566. doi: 10.1016/j.clinthera.2016.03.026 PMID: 27158009
  15. Wirsching, H.G.; Galanis, E.; Weller, M. Glioblastoma. Handb. Clin. Neurol., 2016, 134, 381-397. doi: 10.1016/B978-0-12-802997-8.00023-2 PMID: 26948367
  16. Keyvani, V.; Farshchian, M.; Esmaeili, S.A.; Yari, H.; Moghbeli, M.; Nezhad, S.R.K.; Abbaszadegan, M.R. Ovarian cancer stem cells and targeted therapy. J. Ovarian Res., 2019, 12(1), 120. doi: 10.1186/s13048-019-0588-z PMID: 31810474
  17. Naghibi, F.; Ghafari, S.; Esmaeili, S.; Jenett-Siems, K. Naghibione; A novel sesquiterpenoid with antiplasmodial effect from Dorema hyrcanum koso-pol. Root, a plant used in traditional medicine. Iran. J. Pharm. Res., 2015, 14(3), 961-968. PMID: 26330887
  18. Chakraborty, S.; Rahman, T. The difficulties in cancer treatment. Ecancermedicalscience, 2012, 6, ed16. PMID: 24883085
  19. The global challenge of cancer. Nat. Can., 2020, 1(1), 1-2. doi: 10.1038/s43018-019-0023-9 PMID: 35121840
  20. Delnavazi, M. Antioxidant and antibacterial activities of the essential oils and extracts of Dorema ammoniacum roots and aerial parts. Res. J. Pharmacogn., 2014, 1(4), 11-18.
  21. Bannazadeh, A.M.; Rashtchizadeh, N.; Nazemiyeh, H.; Abdolalizadeh, J.; Mohammadnejad, L.; Baradaran, B. Investigating apoptotic effects of methanolic extract of Dorema glabrum seed on WEHI-164 cells. ISRN Pharmacol., 2013, 2013, 1-9. doi: 10.1155/2013/949871 PMID: 23956872
  22. Jafari, N.; Zargar, S.J.; Yassa, N.; Delnavazi, M.R. Induction of apoptosis and cell cycle arrest by dorema glabrum root extracts in a gastric adenocarcinoma (AGS) cell line. Asian Pac. J. Cancer Prev., 2016, 17(12), 5189-5193. PMID: 28124886
  23. Mohammadi Pour, P.; Bidad, S.; Bahrami, G.; Hosseinzadeh, L.; Mojarrab, M.; Farzaei, M.H. Evaluation of the cytotoxicity of aqueous extract and oleo-essential oil of Dorema ammoniacum plant oleo-gum resin in some human cancer cell lines. Anal. Cell. Pathol., 2022, 2022, 1-9. doi: 10.1155/2022/9725244 PMID: 35983460
  24. Abais, J.M.; Xia, M.; Zhang, Y.; Boini, K.M.; Li, P.L. Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector? Antioxid. Redox Signal., 2015, 22(13), 1111-1129. doi: 10.1089/ars.2014.5994 PMID: 25330206
  25. Chen, H.; Lin, H.; Xie, S.; Huang, B.; Qian, Y.; Chen, K.; Niu, Y.; Shen, H.M.; Cai, J.; Li, P.; Leng, J.; Yang, H.; Xia, D.; Wu, Y. Myricetin inhibits NLRP3 inflammasome activation via reduction of ROS-dependent ubiquitination of ASC and promotion of ROS-independent NLRP3 ubiquitination. Toxicol. Appl. Pharmacol., 2019, 365, 19-29. doi: 10.1016/j.taap.2018.12.019 PMID: 30594691
  26. Mworia, J.K.; Kibiti, C.M.; Ngugi, M.P.; Ngeranwa, J.N. Antipyretic potential of dichloromethane leaf extract of Eucalyptus globulus (Labill) and Senna didymobotrya (Fresenius) in rats models. Heliyon, 2019, 5(12), e02924. doi: 10.1016/j.heliyon.2019.e02924 PMID: 31853510

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers